ES2053778T3 - Procedimiento para la obtencion de derivados del tiazol. - Google Patents

Procedimiento para la obtencion de derivados del tiazol.

Info

Publication number
ES2053778T3
ES2053778T3 ES88400572T ES88400572T ES2053778T3 ES 2053778 T3 ES2053778 T3 ES 2053778T3 ES 88400572 T ES88400572 T ES 88400572T ES 88400572 T ES88400572 T ES 88400572T ES 2053778 T3 ES2053778 T3 ES 2053778T3
Authority
ES
Spain
Prior art keywords
procedure
obtaining
derivatives
tiazol
tiazol derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88400572T
Other languages
English (en)
Inventor
Kathleen Biziere
Dominique Olliero
Paul Worms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Application granted granted Critical
Publication of ES2053778T3 publication Critical patent/ES2053778T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DEL TIAZOL QUE RESPONDEN A LA FORMULA GENERAL (I) EN LA QUE R1, R2, R3, R4 Y R5 TIENEN EL SIGNIFICADO QUE SE DETALLA EN LA INVENCION.
ES88400572T 1987-03-12 1988-03-11 Procedimiento para la obtencion de derivados del tiazol. Expired - Lifetime ES2053778T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8703398A FR2612187B1 (fr) 1987-03-12 1987-03-12 Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
ES2053778T3 true ES2053778T3 (es) 1994-08-01

Family

ID=9348897

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88400572T Expired - Lifetime ES2053778T3 (es) 1987-03-12 1988-03-11 Procedimiento para la obtencion de derivados del tiazol.

Country Status (27)

Country Link
EP (1) EP0283390B1 (es)
JP (1) JPS63243080A (es)
KR (1) KR880011135A (es)
AR (1) AR243515A1 (es)
AT (1) ATE86249T1 (es)
AU (1) AU612350B2 (es)
DD (1) DD274028A5 (es)
DE (1) DE3878708T2 (es)
DK (1) DK170162B1 (es)
ES (1) ES2053778T3 (es)
FI (1) FI881152A7 (es)
FR (1) FR2612187B1 (es)
HU (1) HU198916B (es)
IE (1) IE60173B1 (es)
IL (1) IL85704A (es)
MA (1) MA21207A1 (es)
MY (1) MY103233A (es)
NO (1) NO170081C (es)
NZ (1) NZ223845A (es)
OA (1) OA08871A (es)
PH (1) PH25389A (es)
PL (1) PL151889B1 (es)
PT (1) PT86952B (es)
SU (1) SU1604157A3 (es)
TN (1) TNSN88020A1 (es)
YU (1) YU49688A (es)
ZA (1) ZA881764B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440474A (en) * 1987-08-04 1989-02-10 Hisamitsu Pharmaceutical Co Novel 2-substituted aminothiazole derivative
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
FR2677021B1 (fr) * 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
WO1992021666A1 (fr) * 1991-05-31 1992-12-10 Laboratoires Upsa Derives de thiazole antagonistes de recepteurs a l'angiotensine ii
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
AU4982293A (en) * 1993-03-02 1994-09-26 Fujisawa Pharmaceutical Co., Ltd. Novel heterocyclic compound
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
GB9705428D0 (en) * 1997-03-15 1997-04-30 Knoll Ag Therapeutic agents
EP1087951B9 (en) * 1998-06-18 2006-09-13 Bristol-Myers Squibb Company Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
DK1183245T3 (da) 1999-04-22 2007-09-24 Lundbeck & Co As H Selektive NPY(Y5)-antagonister
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
WO2002083863A2 (en) 2001-04-17 2002-10-24 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
EP1583530A4 (en) * 2002-01-16 2008-07-23 Univ Virginia 2-AMINOTHIAZOLE ALLOSTERIC AMPLIFIERS OF A1 ADENOSINE RECEPTORS
DE10251513A1 (de) * 2002-11-04 2004-05-19 Basf Ag Übergangsmetallkatalysatoren für (Co)Polymerisation von olefinischen Monomeren
JP2007261945A (ja) * 2004-04-07 2007-10-11 Taisho Pharmaceut Co Ltd チアゾール誘導体
WO2006130493A2 (en) * 2005-05-31 2006-12-07 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
KR20110137941A (ko) * 2010-06-18 2011-12-26 (주) 에빅스젠 신규한 티오우레아 또는 우레아 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 ａｉｄｓ 예방 또는 치료용 약학 조성물
RU2456284C1 (ru) * 2011-04-12 2012-07-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" 2-аминопропилморфолино-5-арил-6н-1,3,4-тиадиазины, дигидробромиды и 2-аминопропилморфолино-4-арилтиазолы, гидробромиды, обладающие антиагрегантным действием
CA2967316C (en) 2014-11-10 2021-12-14 Forge Life Science, Llc Anti-hcmv compositions and methods
CN115160207B (zh) * 2022-04-21 2023-09-26 烟台大学 苯甲酰硫脲类化合物及其制备方法和赤潮藻杀藻剂的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975182A (en) * 1959-11-16 1961-03-14 Paul A J Janssen 1-(aroylalkyl)-4-(heterocyclyl) piperazines
FR2092714B1 (es) * 1970-06-11 1974-03-22 Melle Bezons
CH583232A5 (es) * 1973-02-02 1976-12-31 Wander Ag Dr A
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
NL8601494A (nl) * 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
NO881093D0 (no) 1988-03-11
PH25389A (en) 1991-06-03
PT86952B (pt) 1992-05-29
KR880011135A (ko) 1988-10-26
NO170081C (no) 1992-09-09
EP0283390A2 (fr) 1988-09-21
ZA881764B (en) 1988-08-31
MA21207A1 (fr) 1988-10-01
DK128688D0 (da) 1988-03-09
FI881152A0 (fi) 1988-03-11
AU612350B2 (en) 1991-07-11
HUT47261A (en) 1989-02-28
MY103233A (en) 1993-05-29
ATE86249T1 (de) 1993-03-15
OA08871A (fr) 1989-10-31
HU198916B (en) 1989-12-28
IL85704A (en) 1992-11-15
IE60173B1 (en) 1994-06-15
PL151889B1 (en) 1990-10-31
TNSN88020A1 (fr) 1990-07-10
AU1266288A (en) 1988-09-15
NZ223845A (en) 1990-11-27
JPS63243080A (ja) 1988-10-07
DD274028A5 (de) 1989-12-06
IL85704A0 (en) 1988-08-31
FR2612187B1 (fr) 1989-07-21
PT86952A (pt) 1988-04-01
DK170162B1 (da) 1995-06-06
DK128688A (da) 1988-09-13
IE880721L (en) 1988-09-12
NO881093L (no) 1988-09-13
SU1604157A3 (ru) 1990-10-30
DE3878708D1 (de) 1993-04-08
DE3878708T2 (de) 1993-09-02
FR2612187A1 (fr) 1988-09-16
FI881152A7 (fi) 1988-09-13
NO170081B (no) 1992-06-01
AR243515A1 (es) 1993-08-31
EP0283390B1 (fr) 1993-03-03
EP0283390A3 (en) 1988-09-28
PL271132A1 (en) 1988-11-24
YU49688A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2059491T3 (es) Derivados de indol con anillos condensados.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2039269T3 (es) Derivados de azolilmetil-ciclopropilo.
ES2042737T3 (es) Un procedimiento para la preparacion de un glucosido de antraciclina.
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
BG92804A (bg) 4-бензоилизоксазолови производни
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2106463T3 (es) 3-desoxi-oligosacaridos, procedimientos para su obtencion y composiciones farmaceuticas que los contienen.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2039200T3 (es) Derivados isotiazolonicos.
ES2013796A6 (es) Agente cosmetico a base de derivados de pirimidina y retinoides, y procedimiento para prepararlo.
ES2105285T3 (es) Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
NO924681L (no) Syntetiske isohirudiner med forbedret stabilitet
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
ES2036238T3 (es) Derivados de hidroxietil-azolilo.
ES2059396T3 (es) Derivados de indeno y metodos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 283390

Country of ref document: ES